mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |